Teva
Teva collaborates on skin disease treatment, releases targets
Under the agreement with Royalty Pharma, the companies will jointly develop the anti-IL-15 antibody, TEV-'408, which is in a phase 1b trial for the treatment of vitiligo
Teva seeks startups to help solve global pharmaceutical challenges
Placing the focus on the therapist
Does a common heart attack pill help everyone? Studies disagree
Teva joins world’s top 20 pharmaceutical companies
After years of financial and legal problems, Israel’s Teva Pharmaceutical Industries Ltd. named No.19 among the world’s top 20 best-earning pharmaceutical companies.
Women leaders reflect on the tragedy of October 7 and the path forward at WLS Conference
Participants in the panel included Prof. Eilat Shinar (MDA), Talia Tzour Avner (JNF-USA), Amalia Adler-Waxman (Teva), Shari Mendes (Israel Lemonade Fund) and lawyer Ayelet Razin Bet Or.
In the healthcare industry, diversity is crucial to serve patients better, says Teva VP
Amalia Adler-Waxman, Senior Vice President, Global Head of Sustainability and Head of Corporate Affairs of International Markets at Teva, spoke at the Jerusalem Post's Women Leaders Summit.
Support the Soul: 'Teva' campaign to strengthen mental resilience
The Teva company enlisted in the national mission and established "Mental Caregivers", a program to strengthen mental resilience.
'Lending a hand': Teva employees worldwide donate refurbished computers to Israelis affected by war
They collected and shipped hundreds of laptops that had been previously used, now repurposed to aid those affected by the conflict.
Digital innovation can help Israel deal with October 7 trauma. Here's how
Speaking at the Israel Summit, Dr. Eran Harary, a psychiatrist and a Senior Vice President at Teva's Global R&D, explained how Israelis can overcome the shock and find themselves more resilient.
Teva to pay Nevada $193 million over role in opioid epidemic
Nevada, along with other states and thousands of local governments, accused Teva and other drugmakers of downplaying the addiction risks of opioid pain drugs.
US Supreme Court rejects Teva challenge to $235 million GSK award in patent dispute
Israel's Teva Pharmaceuticals and GlaxoSmithKline (GSK) have been disputing over this patent lawsuit since 2014.
Israeli drugmaker Teva says opioids settlement to move forward in US
As a result of the opiod crisis, more than 932,000 people have died in the US since 1999 from a drug overdose.
US Parkinson's disease incidence far higher than earlier estimates -study
Analysis of insurance claims and population growth indicates higher numbers than previously thought - and they will continue to rise.
